-
艾媒咨询|2021年5-6月中国化妆品行业运行数据监测双月报
本报告研究涉及企业/品牌/案例:上海家化,片仔癀,毛戈平,酵色Joocyee
数据显示,2021年1-5月,中国化妆品及洗护用品进口金额为649.8亿元,出口金额为107.2亿元;2021年618购物节的交易额再创新高,其中的美妆类目全网交易总额为5784.8亿元,同比增长26.5%。随着数字技术等高科技快速发展,人工智能、AR、大数据等技术开始逐步被应用到化妆品行业中,化妆品行业开始进入智能时代,应将化妆品和科技更好地结合与创新,从消费者需求出发,为用户带来个性化、智能化的服务。
According to the data, from January to may 2021, the import amount of cosmetics and toiletries in China was 64.98 billion yuan and the export amount was 10.72 billion yuan; In 2021, the transaction volume of 618 Shopping Festival reached a new high, of which the total online transaction volume of beauty category was 578.48 billion yuan, a year-on-year increase of 26.5%. With the rapid development of digital technology and other high technologies, artificial intelligence, AR, big data and other technologies began to be gradually applied to the cosmetics industry. The cosmetics industry began to enter the intelligent era. Cosmetics and technology should be better combined and innovated to bring personalized and intelligent services to users from the needs of consumers. -
艾媒咨询|2020年11-12月中国化妆品行业月度运行及年终盘点数据监测报告
本报告研究涉及企业/品牌/案例:片仔癀,完美日记,薇诺娜
受疫情影响,2020年中国化妆品零售额同比增速从7月才开始恢复正增长,因而后半年以及双11成为化妆品商家发力冲业绩的重点时间段,数据显示,2020双11期间,全网22个电商平台,化妆品销售额超过900亿元。电商促销对化妆品销量的拉升作用明显,成为完美日记、花西子等国产品牌崛起的重要工具,其中国货美妆新品牌完美日记母公司逸仙电商已成功赴美上市。此外,随着男颜经济的崛起、消费者对成分的关注度提升,围绕人群、消费场景细分的产品将会成为新品牌未来发力的重点方向。
Affected by the epidemic, the year-on-year growth rate of China's cosmetics retail sales in 2020 only began to return to positive growth in July. Therefore, the second half of the year and double 11 have become the key periods for cosmetics businesses to make efforts to boost their performance. The data show that during the double 11 period of 2020, there are 22 e-commerce platforms in the whole network, and the sales of cosmetics exceed 90 billion yuan. E-commerce promotion plays an important role in the promotion of cosmetics sales, and has become an important tool for the rise of domestic brands such as perfect diary and huaxizi. Among them, Yixian e-commerce, the parent company of perfect diary, a new brand of Chinese cosmetics, has successfully listed in the United States. In addition, with the rise of men's economy and the increase of consumers' attention to ingredients, products segmented around the crowd and consumption scenarios will become the focus of new brands in the future. -
艾媒咨询|2020年7-8月中国化妆品行业运行数据监测双月报告
本报告研究涉及企业/品牌/案例:片仔癀、欧莱雅、丸美。
疫情影响下,国际和国内化妆品品牌发展态势不同。国际方面,雅诗兰黛、欧莱雅等品牌面临滞涨问题,纷纷裁员。而国内品牌则发展良好,珀莱雅、上海家化等上市公司获得资本市场认可,同时完美日记等品牌也正在寻求新一轮的融资。
As the impact of the epidemic on China has gradually weakened, the cosmetics industry has gradually resumed production and work. Brands such as Estée Lauder and L'Oreal are facing stagflation problems and layoffs. Domestic brands are developing well. Listed companies such as Proya and Shanghai Jahwa have been recognized by the capital market. At the same time, brands such as the emerging Perfect Diary are also seeking a new round of financing. -
艾媒咨询|2020年3-4月中国化妆品及化妆品电商运行数据监测双月报告
本报告研究涉及企业/品牌/案例:壹网壹创,嘉亨家化。
随着国际疫情的衍变,化妆品的用户需求降低和供应链风险增加,令3-4月化妆品行业的压力不容小觑。但从宏观数据看,在3月化妆品价格跌入低谷后,4月有一定的反弹趋势;从平台数据看,2020年4月阿里巴巴全网护肤GMV 为139 亿元,同比增长58.02%。
With the development of the international epidemic, the reduction in user demand for cosmetics and the increase in supply chain risks have made the pressure on the cosmetics industry in March-April not to be underestimated. However, from the macro data, after the price of cosmetics fell into a trough in March, there was a certain rebound trend in April; from the platform data, in April 2020, Alibaba's entire network skin care GMV was 13.9 billion yuan, an increase of 58.02% year-on-year. -
艾媒报告|2019-2021年中国中药材用户调研及延伸市场研究报告
本报告研究涉及企业/品牌/案例:同仁堂,片仔癀,东阿阿胶,太极集团,胡庆余堂,同仁牛黄清心丸,黄芪颗粒,雷氏丹参片,云峰气血口服液,太极五子衍宗丸,太极生力雄丸,仲景左归丸,一笑堂龟甲壳,白云山复方丹参片,天士力养血清脑颗粒,白云山夏桑菊颗粒,白云山板蓝根颗粒
随着居民消费水平的提升和健康保健意识的增强,总体健康需求在扩大,进而推动中医药市场的发展,2018年中国中药材市场规模达1246亿元,同比增长22.40%,预计到2024年,中药材市场规模将达2004亿元。
iiMedia Research(艾媒咨询)调查显示,2019年接近五成受访者购买过中药材,滋补养生和治病是购买中药材的两大目的。由于中医药应用范围广泛,中医药产业链不断扩展延伸,并加速扩展和整合。同仁堂、片仔癀、东阿阿胶等中药巨头企业纷纷布局中药材后市场,建设中药大健康产业,如植物提取物、保健食品、中药化妆品等,已成为我国生命健康产业中最具成长性的组成部分。
According to the iiMedia Research survey, nearly 50% of respondents have bought Chinese herbal medicines in 2019, and tonic sage and cure are the two main purposes for buying Chinese herbal medicines. Due to the wide range of applications of Chinese medicine, the Chinese medicine industry chain continues to expand and expand and accelerate the expansion and integration. Tongrentang, tablets, Dong'a gum and other Chinese medicine giant enterprises have laid out the chinese medicine after the market, the construction of chinese medicine large health industry, such as plant extracts, health food, Chinese medicine cosmetics, etc., has become China's life and health industry in the most growth component.
(以下为节选页,完整版共88页) -
艾媒报告|2019-2021年中国中药材行业发展现状及产业链分析报告
本报告研究涉及企业/品牌/案例:白云山,同仁堂,云南白药,昆明制药,华润三九,天士力,央视财经,牛黄,薏仁,茯苓,黄芪,川芎,片仔癀,中国中药,紫鑫药业,九洲药业,陇神戎发,众生药业,通化金马,江中药业,寿仙谷,新天药业,盘龙药业,佛慈制药,昆药集团,香雪制药,六味地黄丸,人参养荣丸,四神丸,白蚀丸,血脂康胶囊,茵栀黄口服液,一捻金胶囊,乙肝益气解郁颗粒,二十七味定坤丸,十六味冬青丸,参芪消渴胶囊,十香返生丸,华润三九,红日药业,源和药业,太龙药业,中智药业,培力控股,盛实百草,芍花堂,亳药千草,汇群中药
国内经济增长以及居民消费水平的提高都刺激着中药医疗消费需求的增长。iiMedia Research(艾媒咨询)调查显示,有49%的受访用户倾向中医药治疗,与西药基本持平。2018年中国中药材市场规模达1246亿元,同比增长22.40%,在巨大的需求驱动下,中药材种植面积扩大,药材产量将会持续增长。
中药材主要包括上游种植、养殖市场,中游流通市场和下游销售市场三大环节。目前,中药饮片和中成药生产是中药产业的核心,主要包括中药加工,包括中药配方颗粒、中药饮片加工、中成药制造等。中药饮片领域方面,行业销售收入增速分别在2016和2018年触底回升,华润三九、中国中药、红日药业等上市公司表现良好;中药配方颗粒方面,2006-2016年,中国市场销售额占饮片市场销售额比重由1.2%增加至6.0%,中药配方颗粒或将成为中药饮片加工行业应用广泛的产品;中成药方面,随着国家医改政策的推行,中成药消费需求趋于合理,中成药产量开始回落,但仍处于一个比较高的产量水平,云南白药、白云山、同仁堂、紫鑫药业等上市企业表现良好。
Chinese medicinal materials mainly include upstream planting, breeding market, midstream circulation market and downstream sales market three links. At present, the production of Chinese medicine tablets and traditional Chinese medicine is the core of the Chinese medicine industry, including the processing of Traditional Chinese medicine, including Chinese medicine formula particles, Chinese medicine tablet processing, traditional Chinese medicine manufacturing. In the field of Chinese medicine tablets, the growth rate of sales revenue in the industry rebounded in 2016 and 2018, respectively, china Resources 39, Chinese medicine, Red Day Pharmaceuticals and other listed companies performed well; Chinese medicine formula particles may become a widely used product in the Chinese medicine tablet processing industry, Chinese medicine, with the implementation of the national medical reform policy, the consumption demand of traditional Chinese medicine tends to be reasonable, the production of Traditional Chinese medicine began to fall, but still at a relatively high level of production, Yunnan White Medicine, Baiyunshan, Tongrentang, Zixin Pharmaceutical and other listed enterprises performed well.
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告